GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

The Health Secretary will set out a 10-year plan including proposals to bring down the cost of drugs such as Wegovy and ...

UnitedHealth Group’s ( UNH) new CEO, Stephen Hemsley, is shaking up the senior management of the company, appointing Patrick Conway, newly named CEO of the managed care giant’s Optum unit, as the head ...

One of the main researchers, Professor Tore Bengtsson from Stockholm University, said this could be an exciting step forward.

Hims & Hers extended its rally for the second day on Friday, adding 6.76 percent to close at $49.41 apiece after its chief ...

In the M-ACCEL trial, HU6-induced weight loss was exclusively attributed to fat loss, with no statistically significant loss ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

A knock-on effect from the use Ozempic is a change of diet, including a reliance on caffeine and low carbs. However, this ...

There are a few potential risks to keep in mind with rice water, including some food safety concerns.

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...